Suppr超能文献

人类免疫缺陷病毒1型蛋白酶和逆转录酶基因在接受高效抗逆转录病毒治疗(HAART)失败个体与初治个体之间的差异进化。

Differential evolution of Human Immunodeficiency Virus type 1 Protease and Reverse Transcriptase genes between HAART-failing and naïve-treated individuals.

作者信息

Varella Rafael B, Schrago Carlos G, Zalis Mariano G

机构信息

Department of Infectious Diseases UNIFESO, A2-097, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Curr HIV Res. 2009 Nov;7(6):601-5. doi: 10.2174/157016209789973664.

Abstract

We described differential selective pressures along codon sites of the RT and PR genes of HIV-1 from HAART-failing and naïve-treated individuals, through the comparison of the ratio of non-synonymous mutations (d(N)) to synonymous mutations (d(S)) substitution per site. Resistance-associated mutations were found in 1/71 (1.4%) and 109/117 (93.1%) samples from naïve-treated and HAART-failing individuals, respectively, although most of positively selected codons represented polymorphisms in positions 123, 211, 245, 297 in RT and 37, 63 in PR of naïve-treated samples and positions 122, 123, 245, 272, 277, 286, 297 in RT and 10, 15, 20, 35, 37, 62, 63, 64, 71, 72, 77, 93 in PR of HAART-failing samples, except by ARV-resistance codons 74, 184, 215 in RT and 90 in PR exclusively found in HAART-failing group. The number and diversity of sites under selective pressure at populational level also increased in RT but not in PR of treated individuals. Our results demonstrated no evolution of drug-associated codons among untreated individuals, indicating unlikely transmission and adaptation of resistant HIV-1 strains in a free drug environment. Polymorphic sites observed exclusively in HAART-failing group, may contribute to HIV-1 escape and adaptation at individual and populational levels in a drug environment, although those mutually found in HIV-1 despite of previous exposure to ARV treatment, should not be considered accurate resistance markers.

摘要

通过比较每位点非同义突变(d(N))与同义突变(d(S))的替换率,我们描述了来自接受高效抗逆转录病毒治疗(HAART)失败个体和初治个体的HIV-1逆转录酶(RT)和蛋白酶(PR)基因密码子位点上的差异选择压力。在初治个体和HAART失败个体的样本中,分别有1/71(1.4%)和109/117(93.1%)发现了耐药相关突变,尽管大多数正选择密码子在初治样本的RT基因的123、211、245、297位点以及PR基因的37、63位点,以及HAART失败样本的RT基因的122、123、245、272、277、286、297位点和PR基因的10、15、20、35、37、62、63、64、71、72、77、93位点表现为多态性,但HAART失败组中RT基因的74、184、215位点和PR基因的90位点为抗逆转录病毒药物(ARV)耐药密码子,这些位点除外。在接受治疗个体中,RT基因在群体水平上受选择压力作用的位点数量和多样性也增加了,但PR基因没有。我们的结果表明,未治疗个体中与药物相关的密码子没有进化,这表明在无药物环境中耐药HIV-1毒株不太可能传播和适应。仅在HAART失败组中观察到的多态性位点,可能在药物环境中促成HIV-1在个体和群体水平上的逃逸和适应,尽管那些在曾接受ARV治疗的HIV-1中也能发现的位点,不应被视为准确的耐药标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验